Skip to main navigationSkip to main content
The University of Southampton
Medicine

Professor John Primrose MB, ChB (Honours), FRCS, MD

Professor of Surgery

Professor John Primrose's photo

Professor John Primrose is Professor of Surgery within Medicine at the University of Southampton.

Professor John Primrose is Professor of Surgery at the University of Southampton, a post he has held since 1994. He is one of the few surgeons to be the UK Academy of Medical Sciences and is an NIHR Senior Investigator. He trained in Glasgow and Leeds where he was Lecturer and then Senior Lecturer in Surgery. His clinical interest is in cancer, particularly hepatobiliary (HPB) cancer and Southampton is a large tertiary referral centre for HPB disease. It is the largest laparoscopic HPB centre in the UK.

His research interest is gastrointestinal cancer, clinical and translational, principally liver and colorectal.  He is Chief Investigator of several major national and international clinical trials and has changed global practice in 3 critical areas.  He is highly published with an “H” factor of 50. 

He currently Chairs Deutche Krebshilfe (German Cancer Aid) Translational Funding Committee and serves on the MRC Clinical Training Board and the UKRI Future Leaders Panel.  Previously he was a member of numerous CRUK Committees and was Chair of the NCRI Upper GI Clinical Studies Group. 

From 2007 to 2017 he was Director of the NIHR Hampshire and Isle of Wight Comprehensive Local Research Network promoting a research led NHS.  He was elected Vice President and then President of the Association of Surgeons of Great Britain and Ireland, the principle membership organisation for surgeons in the British Isles.  He is (joint) Editor in Chief of the Oxford Textbook of General Surgery.  He holds Honorary Chairs at the University of Glasgow (his alma mater) and Emory University, Atlanta.

Qualifications

Appointments held

Research interests

Professor Primrose’s research is in gastrointestinal cancer, clinical and translational and Health Services Research. The focus is on improving outcomes for patients undergoing surgical treatment for cancer. This is being achieved through devising and undertaking large scale national and international trials. All the studies are associated with tissue collections with a view to the development of biomarkers which will have prognostic value and may also predict response to therapy.

Colorectal cancer

The FACS trial is the definitive randomised trial examining means of patients with colorectal liver metastases and has changed practice globally. This Health Technology Assessment Programme funded trial has run since 2003 and a final survival review is currently planned. The trial studied various interventions used in the follow up of patients with colorectal cancer following surgery. The analysis published in JAMA shows that more intensive follow up results in more patients having intervention for recurrence but with no effect on mortality over less intensive observations. Translational analysis of collected tissue should add prognostic information which may determine whether a patient requires surveillance.

The EPOC trial, supported by CRUK and reported in the Lancet, showed that the addition of chemotherapy to surgery for colorectal liver metastases improves the progression free survival. The follow-on trial, New EPOC, also funded by CRUK examined whether the addition of cetuximab, an anti EGF receptor antibody, to chemotherapy improves the outcome still further. Surprisingly this showed cetuximab resulted in a 2 year reduction in overall survival (Lancet Oncology), a phenomenon unexplained by any trial related factors. Death was due to rapidly progressive multi-site metastasis (Br J Cancer). This detriment occurs principally in the patients with what may be considered to have the best outlook. It has been shown that the detriment can be predicted by the expression of microRNA Mir21 (Oncotarget). A full multiomics analysis of primary tumour and liver metastases is currently underway via the MRC/CRUK funded S:CORT collaborative to fully clarify the biological basis of the findings. 

Other work has attempted to clarify the role of minimally invasive surgery in liver and pancreatic malignancy (Annals of Surgery and others)

Biliary tract cancer

The BILCAP trial is examining whether adjuvant chemotherapy may improve the outcome of biliary tract cancer (cholangiocarcinoma and gallbladder cancer). This is funded by CRUK as are the associated translational studies. We have demonstrated a 16-month improvement in survival in the chemotherapy treated patients and this has been adopted as global standard of care. He is now in receipt of a large industrial grant to sequence the tumours from the tissue blocks to gain insights into the mutational and expression characteristics of bile duct cancer, correlations with treatments and the discovery of the frequency of actionable mutations.

 

PhD supervision

Numerous MD and PhD student mainly co-supervised

Over the last decade surgery has had 5 MRC Clinical Training Fellowship Awards and several from CRUK

Research group

Cancer Sciences

Affiliate research groups

Clinical and Experimental Sciences, Primary Care, Population Sciences and Medical Education

Professor Primrose has led the development of Academic Surgery within the Cancer Sciences Division of the Faculty since 1994. He has supervised the research of a large number of postgraduate students some of whom are now senior academics. Presently he is a Member of the MRC Clinical training Board and Chairs German Cancer Aid Translational Committee. He Chaired the NICE Guidelines Committee on Pancreatic Cancer and has been appoint to Chair the NICE Guidelines on Barrett’s Oesophagus. From 2007 to 2017 he directed the Hampshire and Isle of Wight Comprehensive Research Network which administers a budget of around £9M of funding and transformed clinical research in the region. As Chair of the National Cancer Research Institute Upper GI Cancer studies group, he oversees a large portfolio of research trials, both clinical and translational. From 2006 to 2009 he was Director of Education at the Association of Surgeons and was responsible for setting up a distance learning Masters Programme in Surgical Education and involved in the development of the General Surgical training Curriculum. As President of the Association provided leadership of the organization and for surgeons in the UK and Ireland.

Sort via:TypeorYear

Articles

Book

Book Chapters

  • Primrose, J. N., & Underwood, T. J. (2013). Stomach and duodenum. In N. Williams, C. Bulstrode, & P. R. O'Connell (Eds.), Bailey & Love's Short Practice of Surgery, 26th edition (pp. 1023-1057). Boca Raton, US: CRC Press.
  • Primrose, J. N. (2008). Stomach and duodenum. In N. S. Williams, C. J. K. Bulstrode, & P. R. O'Connell (Eds.), Bailey & Love's Short Practice of Surgery 25th edition (pp. 1045-1079). London, GB: Edward Arnold.
  • Primrose, J. N. (2004). Stomach and duodenum. In Bailey & Love's Short Practice of Surgery 24th Edn (pp. 1026-1061). London, GB: Arnold.
  • Primrose, J. N. (2000). Stomach and Duodenum. In H. Bailey, R. J. M. Love, R. C. G. Russell, N. S. Williams, & C. J. K. Bulstrode (Eds.), Bailey and Love's Short Practice of Surgery 23rd Edition (pp. 891-930). London, GB: Hodder Arnold.

Letter/Editorial

Reports

Reviews

Professor Primrose lectures widely nationally and internationally on gastrointestinal cancer, surgical and oncological treatment and translational science. He is dedicated to the training of the next generation of clinical academic surgeons and surgeons with a specialty experience surgery of the liver and pancreas.

Professor John Primrose
Faculty of Medicine, University of Southampton, Building 85, Life Sciences Building, Highfield Campus, Southampton, SO171BJ

Room Number: SGH/AC65/MP816

Share this profile Share this on Facebook Share this on Twitter Share this on Weibo
Privacy Settings